EUVIMEDEUVIMED entdecken
Crossref

Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression

P P Mubthasima, Anbarasu Kannan

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02508-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von P P Mubthasima und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Exosome Biology Laboratory, Department of Biochemistry, CSIR- Central Food Technological Research Institute, Mysuru, 570020, India. Hauptthemen laut MEDLINE: Receptor, EphA2, Estradiol, Uterine Cervical Neoplasms, Cell Movement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remained among the most prevalent cancers in women. Erythropoietin-producing hepatocellular A2 (EPHA2) is overexpressed in many cancers, including cervical cancer, and the mechanism by which it regulates cervical cancer progression is not yet fully understood. Exosomes are extracellular vesicles that carry information in the form of biomolecules, deliver it to the recipient cell, and play a vital role in cellular communication. 17β-Estradiol is the natural female steroid hormone with the greatest estrogenic activity, and it induces cell death in cancer. In this study, we investigated the function of EPHA2 in cervical cancer migration and immunomodulation and the presence of EPHA2 in the cervical cancer serum-derived exosome. A knockdown of EPHA2 (KD-EPHA2) in cervical cancer reduces cancer cell migration by regulating the CD113/Ezrin pathway. Furthermore, EPHA2 exhibited significant involvement in immunomodulation by orchestrating IL-6-mediated signalling cascades, including the AKT-mTOR and JAK-STAT pathways. Immune infiltration analysis revealed a correlation between EPHA2 expression in cervical cancer and the infiltration of various immune cell populations. KD-EPHA2 enhances the 17β-Estradiol inhibitory effect on cell proliferation and migration during cancer progression. In summary, our study revealed that EPHA2 is overexpressed in cervical cancer and plays a vital role in cancer cell migration and immunomodulation, and 17β-Estradiol, along with KD-EPHA2, enhances the inhibitory effect on cancer cell migration and proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, EphA2EstradiolUterine Cervical NeoplasmsCell MovementDisease ProgressionImmunomodulationHumansFemaleCell ProliferationCell Line, TumorExosomesSignal Transduction

Stichwörter der Autor:innen

17β-EstradiolEPHA2ExosomeImmune infiltrationImmunomodulation

Substanzen

Receptor, EphA2EstradiolEPHA2 protein, human

Autor:innen und Institutionen

  • Cancer and Exosome Biology Laboratory, Department of Biochemistry, CSIR- Central Food Technological Research Institute, Mysuru, 570020, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Cancer and Exosome Biology Laboratory, Department of Biochemistry, CSIR- Central Food Technological Research Institute, Mysuru, 570020, India. anbarasu@cftri.res.in.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. anbarasu@cftri.res.in.

Zitieren

APA

Mubthasima, P. P., & Kannan, A. (2024). Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression. Medical Oncology. https://doi.org/10.1007/s12032-024-02508-0

Vancouver

Mubthasima PP, Kannan A. Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression. Medical Oncology. 2024. doi:10.1007/s12032-024-02508-0

BibTeX
@article{Mubthasima2024,
  author = {Mubthasima, P P and Kannan, Anbarasu},
  title = {Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02508-0}
}
Kostenlos starten →